Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration

The aim of this study was to establish the pharmacokinetics of levofloxacin (LVFX) and determine the optimal dose of this drug in critically ill patients receiving continuous hemodiafiltration (CHDF). The results of in vivo and in vitro studies showed the pharmacokinetics of LVFX total clearance (CL...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Intensive Care
Главные авторы: Wada, Takeshi, Kobayashi, Masaki, Ono, Yuichi, Mizugaki, Asumi, Katabami, Kenichi, Maekawa, Kunihiko, Miyamoto, Daisuke, Yanagida, Yuichiro, Hayakawa, Mineji, Sawamura, Atsushi, Iseki, Ken, Gando, Satoshi
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Letter to the Editor
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4436099/
https://ncbi.nlm.nih.gov/pubmed/25992293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40560-015-0089-0
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы